EMEA-001501-PIP02-13-M04

Key facts

Invented name
Dupixent
Active substance
dupilumab
Therapeutic area
Pneumology-allergology
Decision number
P/0011/2020
PIP number
EMEA-001501-PIP02-13-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Sanofi-Aventis Recherche & Développement 

Tel. +33 169745695
E-mail: contact-us@sanofi.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating